Blog
Mantidisflavin A
In this compound the riboflavin skeleton was supplemented by the formation of two additional fused heterocycles through a novel C−C bond and an oxygen bridge on the riboflavin backbone. The structure of mantidisflavin A (molecular formula C17H19N4O6) was elucidated using 1D and 2D NMR spectra in combination with HR-ESI-MS and IR.
Webinar
DMTA Innovation at Takeda—Digitalized, AI-Augmented, Autonomous
Discover how Takeda is accelerating chemical process development with AI-enabled high-throughput experimentation (HTE), automation, and integrated hardware/software. Hear real-world success stories of shortening project times from weeks to days; and how technology partnerships are accelerating autonomous, AI-guided workflows in pharmaceutical R&D.
June 24th @ 10:00 EST, Register Now
Blog
Navigating Drug Design in ‘Beyond the Rule of 5’ Landscape
As drug discovery expands beyond traditional boundaries, complex small molecules like PROTACs challenge old rules. Discover how ACD/Labs’ predictive platforms help scientists design bioavailable, scalable drugs in the evolving ‘bRo5’ space with precision and confidence.
Webinar
Streamline Stability Decisions in Pharmaceutical Development
J. DiMartino, ACD/LabsThis webinar highlights how Luminata® simplifies pharmaceutical stability decisions by integrating forced degradation and APS data. Learn to visualize analytical data, map degradant pathways, and model stability trends for faster, more informed decision-making.
Application Note
Augmentation of ACD/Labs pKa® Prediction Algorithm with Proprietary High-Quality Data
Discover how ACD/Labs teamed up with AstraZeneca to enhance pKa predictions. By integrating proprietary experimental data and refining prediction algorithms, we unlocked new insights and accuracy gains – paving the way for more confident decision-making in modern drug discovery.